AptarGroup nasal spray tech joins ENA respiratory’s Phase II trial of INNA?051
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
At the center of the collapse is opposition from the Federal Trade Commission
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Subscribe To Our Newsletter & Stay Updated